Pacira BioSciences, Inc.

Annual Trend FY 2016 FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
ASSETS
Current assets:
Cash and Cash Equivalents, at Carrying Value $35.9m $54.1m $132.5m $78.2m $100.0m $585.6m $104.1m $153.3m $276.8m $158.5m
Prepaid Expense and Other Assets, Current $9.3m $6.7m $7.9m $10.8m $12.3m $14.8m $15.2m $21.5m $21.9m $32.6m
Short-term Investments $136.7m $257.2m $250.9m $213.7m $421.7m $70.8m $184.5m $125.3m $207.8m $79.9m
Inventory, Net $31.3m $41.4m $48.6m $58.3m $64.7m $98.5m $96.1m $104.4m $125.3m $152.9m
Assets, Current $243.1m $391.1m $478.0m $408.6m $651.6m $866.0m $498.3m $510.0m $745.1m $548.0m
Property, Plant and Equipment, Net $101.0m $107.0m $108.7m $104.7m $136.7m $188.4m $183.5m $173.9m $167.2m $140.7m
Goodwill $46.7m $55.2m $62.0m $99.5m $99.5m $145.2m $163.2m $163.2m $0 $20.2m
Intangible Assets, Net (Excluding Goodwill) $104.4m $96.5m $624.0m $540.5m $483.3m $426.0m $368.1m
Operating Lease, Right-of-Use Asset $38.1m $74.5m $76.4m $70.9m $61.0m $49.2m $41.8m
Other Assets, Noncurrent $624k $825k $657k
Additional Financial Items
Accounts Receivable, after Allowance for Credit Loss, Current $29.9m $31.7m $38.0m $47.5m $53.0m $96.3m $98.4m $105.6m $113.3m $124.1m
Accrued Liabilities, Current $36.7m $41.1m $45.9m $70.4m $71.0m $127.6m $89.8m $64.2m $80.1m $95.6m
Assets $391.5m $628.4m $689.4m $831.1m $1.3b $2.1b $1.7b $1.6b $1.6b $1.3b
LIABILITIES AND EQUITY
Current liabilities:
Operating Lease, Liability, Current $4.9m $7.4m $7.9m $9.1m $8.8m $8.9m $9.8m
Accounts Payable, Current $7.5m $14.7m $14.4m $12.8m $10.4m $10.5m $15.2m $15.7m $19.1m $15.2m
Operating Lease, Liability, Noncurrent $40.9m $71.0m $71.7m $64.8m $54.8m $44.6m $36.2m
Deferred Revenue, Current $595k $102k $0
Deferred Revenue, Noncurrent $7.5m
Long-term Debt, Excluding Current Maturities $108.7m $0 $24.2m $33.6m $522.4m $585.3m $372.2m
Long-term Debt, Current Maturities $118.5m $0 $24.2m $33.6m $522.4m $585.3m $0
Liabilities, Current $44.8m $56.2m $60.7m $107.7m $253.3m $521.1m $147.8m $97.4m $309.9m $120.6m
Deferred Income Tax Liabilities, Net $0 $4.2m
Other Liabilities, Noncurrent $11.4m $16.5m $16.9m $1.5m $3.8m $9.8m $9.7m $13.6m $16.8m $20.6m
Liabilities $172.5m $348.9m $368.1m $476.1m $654.8m $1.3b $906.2m $704.3m $775.2m $571.8m
Stockholders’ equity:
Preferred Stock, Value, Issued $0 $0 $0 $0 $0 $0 $0 $0 $0 $0
Common Stock, Value, Issued $37k $41k $41k $42k $44k $45k $46k $46k $47k $48k
Additional Paid in Capital $565.2m $669.0m $709.7m $754.0m $873.2m $942.1m $924.1m $976.6m $1.0b $1.1b
Retained Earnings (Accumulated Deficit) ($346.2m) ($389.1m) ($388.2m) ($399.4m) ($253.9m) ($211.9m) ($148.8m) ($106.8m) ($206.4m) ($199.3m)
Accumulated Other Comprehensive Income (Loss), Net of Tax ($30k) ($454k) ($280k) $322k $318k $167k ($380k) $247k $343k $4.3m
Stockholders' Equity Attributable to Parent $219.0m $279.5m $321.2m $354.9m $619.7m $730.4m $775.0m $870.1m $778.3m $693.1m
Liabilities and Equity $391.5m $628.4m $689.4m $831.1m $1.3b $2.1b $1.7b $1.6b $1.6b $1.3b

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.